Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Page 1
Long-term quality of life and functional outcome of patients with juvenile idiopathic arthritis in the biologic era: a longitudinal follow-up study in the Dutch Arthritis and Biologicals in Children Register.
Rheumatology (Oxford). 2015 Nov;54(11):1964-9. doi: 10.1093/rheumatology/kev195. Epub 2015 Jun 14.
Rheumatology (Oxford). 2015.
PMID: 26078219
RESULTS: Forty-three patients (81% response) started etanercept a median 8.5 years ago. At the time of this long-term analysis, median age was 22 years (interquartile range: 18-24 years). ...
RESULTS: Forty-three patients (81% response) started etanercept a median 8.5 years ago. At the time of this long-term analysis, media …
Trends in prescription of biological agents and outcomes of juvenile idiopathic arthritis: results of the Dutch national Arthritis and Biologics in Children Register.
Otten MH, Anink J, Prince FH, Twilt M, Vastert SJ, ten Cate R, Hoppenreijs EP, Armbrust W, Gorter SL, van Pelt PA, Kamphuis SS, Dolman KM, Swart JF, van den Berg JM, Koopman-Keemink Y, van Rossum MA, Wulffraat NM, van Suijlekom-Smit LW.
Otten MH, et al.
Ann Rheum Dis. 2015 Jul;74(7):1379-86. doi: 10.1136/annrheumdis-2013-204641. Epub 2014 Mar 18.
Ann Rheum Dis. 2015.
PMID: 24641940
CONCLUSIONS: Biological agents are increasingly prescribed, earlier in the disease and in patients with JIA with lower disease activity. These changes are accompanied by better short-term disease outcomes....
CONCLUSIONS: Biological agents are increasingly prescribed, earlier in the disease and in patients with JIA with lower disease activity. The …
Item in Clipboard
Efficacy of biological agents in juvenile idiopathic arthritis: a systematic review using indirect comparisons.
Otten MH, Anink J, Spronk S, van Suijlekom-Smit LW.
Otten MH, et al.
Ann Rheum Dis. 2013 Nov;72(11):1806-12. doi: 10.1136/annrheumdis-2012-201991. Epub 2012 Nov 21.
Ann Rheum Dis. 2013.
PMID: 23172748
Review.
Indirect comparisons identified no significant differences in short-term efficacy. Network 2 indirectly compared trials with a parallel study design investigating anakinra, tocilizumab and canakinumab in systemic JIA; no differences in comparative efficacy were identified. …
Indirect comparisons identified no significant differences in short-term efficacy. Network 2 indirectly compared trials with a parall …
Item in Clipboard
Long-term safety of tegaserod in patients with constipation-predominant irritable bowel syndrome.
Tougas G, Snape WJ Jr, Otten MH, Earnest DL, Langaker KE, Pruitt RE, Pecher E, Nault B, Rojavin MA.
Tougas G, et al. Among authors: otten mh.
Aliment Pharmacol Ther. 2002 Oct;16(10):1701-8. doi: 10.1046/j.1365-2036.2002.01347.x.
Aliment Pharmacol Ther. 2002.
PMID: 12269961
Free article.
Clinical Trial.
Oral administration causes gastrointestinal effects resulting in increased gastrointestinal motility and attenuation of visceral sensation. AIM: : To determine the long-term safety and tolerability of tegaserod in patients suffering from irritable bowel syndrome with const …
Oral administration causes gastrointestinal effects resulting in increased gastrointestinal motility and attenuation of visceral sensation. …
Item in Clipboard
The role of dietary fat in peripheral thyroid hormone metabolism.
Otten MH, Hennemann G, Docter R, Visser TJ.
Otten MH, et al.
Metabolism. 1980 Oct;29(10):930-5. doi: 10.1016/0026-0495(80)90035-9.
Metabolism. 1980.
PMID: 7421583
Short term changes in serum 3,3',5-triiodothyronine (T3) and 3,3'5-triiodothyronine (reverse T3, rT3) were studied in four healthy nonobese male subjects under varying but isocaloric and weight maintaining conditions. ...
Short term changes in serum 3,3',5-triiodothyronine (T3) and 3,3'5-triiodothyronine (reverse T3, rT3) were studied in four healthy no …
Item in Clipboard
Cite
Cite